Top

Published in:

Open Access 01-12-2013 | Research article

MLPA-based genotype–phenotype analysis in 1053 Chinese patients with DMD/BMD

Authors: Juan Yang, Shao Y Li, Ya Q Li, Ji Q Cao, Shan W Feng, Yan Y Wang, Yi X Zhan, Chang S Yu, Fei Chen, Jing Li, Xiao F Sun, Cheng Zhang

Published in: BMC Medical Genetics | Issue 1/2013

Abstract

Background

Large-scale analysis of the transmission, mutation characteristics and the relationship between the reading frame and phenotype of the DMD gene has previously been performed in several countries, however, analogous studies have yet to be performed in Chinese populations.

Methods

Clinical data from 1053 Chinese patients with DMD/BMD were collected, and the DMD gene was tested by MLPA in all patients and 400 proband mothers. In 20 patients with negative MLPA, sequencing was also performed.

Results

We found that 27.50% of cases had a family medical history of DMD/BMD, and large rearrangements were identified in 70.56% of the probands, of which 59.35% and 11.21% were deletions or duplications, respectively. The carrier status of the mothers in the study was determined to be 50.75%, and it was established that the DMD mutation was inherited from the mother in 51.72% of the probands. Exons 45–54 and 3–22 were the most frequently deleted regions, and exons 3–11 and 21–37 were the most prevalently duplicated regions of the gene. Breakpoints mainly occurred in introns 43–55 for deletion mutations and in introns 2 and 7 for duplication mutations. No breakpoints were found at the 5^′ or 3^′ end of introns 31, 35, 36, 40, 65, 68, and 74–78 in any of the deletion or duplication mutations. The reading frame rule held true for 86.4% of the DMD patients and 74.55% of the BMD patients.

Conclusion

It is essential to increase physicians’ understanding of DMD/BMD, to promote scientific information, and to increase awareness in regards to genetic counseling and prenatal diagnosis in pedigrees with a family history of the disease, particularly in families with small DMD lesions in China. In addition, such a large-scale analysis will prove to be instructive for leading translational studies between basic science and clinical medicine.

Available only for authorised users

Davies KE, Pearson PL, Harper PS, et al: Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. Nucl Acids Res. 1983, 11 (8): 2303-2312. 10.1093/nar/11.8.2303.CrossRefPubMedPubMedCentral

Kingston HM, Thomas NS, Pearson PL, et al: Genetic linkage between Becker muscular dystrophy and a polymorphic DNA sequence on the short arm of the X chromosome. J Med Genet. 1983, 20 (4): 255-258. 10.1136/jmg.20.4.255.CrossRefPubMedPubMedCentral

Hoffman EP, Brown RH, Kunkel LM: Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987, 51 (6): 919-928. 10.1016/0092-8674(87)90579-4.CrossRefPubMed

Bushby KM, Thambyayah M, Gardner-Medwin D: Prevalence and incidence of Becker muscular dystrophy. Lancet. 1991, 337 (8748): 1022-1024. 10.1016/0140-6736(91)92671-N.CrossRefPubMed

Emery AE: Population frequencies of inherited neuromuscular diseases: a world survey. Neuromuscul Disord. 1991, 1 (1): 19-29. 10.1016/0960-8966(91)90039-U.CrossRefPubMed

Hoffman EP, Fischbeck KH, Brown RH, et al: Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne’s or Becker’s muscular dystrophy. N Engl J Med. 1988, 318 (21): 1363-1368. 10.1056/NEJM198805263182104.CrossRefPubMed

Nicholson LV, Johnson MA, Gardner-Medwin D, et al: Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol. 1990, 80 (3): 239-250. 10.1007/BF00294640.CrossRefPubMed

Schouten JP, McElgunn CJ, Waaijer R, et al: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002, 30 (12): e57-10.1093/nar/gnf056.CrossRefPubMedPubMedCentral

Roberts RG, Barby TF, Manners E, et al: Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet. 1991, 49 (2): 298-310.PubMedPubMedCentral

10.

den Dunnen JT, Antonarakis SE: Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 2000, 15 (1): 7-12. 10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N.CrossRefPubMed

11.

Janssen B, Hartmann C, Scholz V, et al: MLPA analysis for the detection of deletion, duplication and complex arrangements in the dystrophin gene: potential and pitfalls. Neurogenetics. 2005, 6 (1): 29-35. 10.1007/s10048-004-0204-1.CrossRefPubMed

12.

Gatta V, Scarciolla O, Gaspari AR, et al: Identification of deletions and duplications of the DMD gene in affected males and carrier females by multiple ligation probe amplification (MLPA). Hum Genet. 2005, 117 (1): 92-98. 10.1007/s00439-005-1270-7.CrossRefPubMed

13.

Tuffery-Giraud S, Béroud C, Leturcq F, et al: Genotype–Phenotype Analysis in 2,405 Patients with a Dystrophinopathy Using the UMD–DMD Database: A Model of Nationwide Knowledgebase. Hum Mutat. 2009, 30 (6): 934-945. 10.1002/humu.20976.CrossRefPubMed

14.

Hu XY, Ray PN, Worton RG: Mechanisms of tandem duplication in the Duchenne muscular dystrophy gene include both homologous and nonhomologous intrachromosomal recombination. EMBO J. 1991, 10 (9): 2471-2477.PubMedPubMedCentral

15.

Zhang Z, Takeshima Y, Awano H, et al: Tandem duplications of two separate fragments of the dystrophin gene in a patient with Duchenne muscular dystrophy. J Hum Genet. 2008, 53 (3): 215-219. 10.1007/s10038-007-0235-1.CrossRefPubMed

16.

White SJ, Aartsma-Rus A, Flanigan KM, et al: Duplications in the DMD gene. Hum Mutat. 2006, 27 (9): 938-945. 10.1002/humu.20367.CrossRefPubMed

17.

Gangopadhyay SB, Sherratt TG, Heckmatt JZ, et al: Dystrophin in frameshift deletion patients with Becker muscular dystrophy. Am J Hum Genet. 1992, 51 (3): 562-570.PubMedPubMedCentral

18.

Malhotra SB, Hart KA, Klamut HJ, et al: Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science. 1988, 242 (4879): 755-759. 10.1126/science.3055295.CrossRefPubMed

19.

Chelly J, Gilgenkrantz H, Lambert M, et al: Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell. 1990, 63 (6): 1239-1248. 10.1016/0092-8674(90)90419-F.CrossRefPubMed

20.

Gualandi F, Rimessi P, Trabanelli C, et al: Intronic breakpoint definition and transcription analysis in DMD/BMD patients with deletion/duplication at the 5’ mutation hot spot of the dystrophin gene. Gene. 2006, 370: 26-33.CrossRefPubMed

21.

Winnard AV, Mendell JR, Prior TW, et al: Frameshift deletions of exons 3–7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Am J Hum Genet. 1995, 56 (1): 158-166.PubMedPubMedCentral

22.

Yin H, Moulton HM, Seow Y, et al: Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function. Hum Mol Genet. 2008, 17 (24): 3909-3918. 10.1093/hmg/ddn293.CrossRefPubMed

23.

Cirak S, Arechavala-Gomeza V, Guglieri M, et al: Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet. 2011, 378 (9791): 595-605. 10.1016/S0140-6736(11)60756-3.CrossRefPubMedPubMedCentral

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/14/29/prepub

Title: MLPA-based genotype–phenotype analysis in 1053 Chinese patients with DMD/BMD
Authors: Juan Yang
Shao Y Li
Ya Q Li
Ji Q Cao
Shan W Feng
Yan Y Wang
Yi X Zhan
Chang S Yu
Fei Chen
Jing Li
Xiao F Sun
Cheng Zhang
Publication date: 01-12-2013
Publisher: BioMed Central
Published in: BMC Medical Genetics / Issue 1/2013
Electronic ISSN: 1471-2350
DOI: https://doi.org/10.1186/1471-2350-14-29

Keynote webinar | Spotlight on medication adherence

Springer Medicine

MLPA-based genotype–phenotype analysis in 1053 Chinese patients with DMD/BMD

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2013

Re-sequencing of the APOAI promoter region and the genetic association of the -75G > A polymorphism with increased cholesterol and low density lipoprotein levels among a sample of the Kuwaiti population

Association between UCP2A55V polymorphism and risk of cardiovascular events in patients with multi-vessel coronary arterial disease

Genetics of coronary artery calcification among African Americans, a meta-analysis

Inherited KIF21A and PAX6 gene mutations in a boy with congenital Fibrosis of extraocular muscles and aniridia

Effects of vitamin D receptor polymorphisms on urolithiasis risk: a meta-analysis

Development and validation of a multiplex-PCR assay for X-linked intellectual disability